Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

Presentation THT 2025

Safety and Feasibility of Renal Venous Afterload Modulation With the Doraya in Acute Decompensated Heart Failure and Persistent Congestion From Insufficient Response to Diuretic Therapy

Presenter: Lucas Zier

February 13, 2025

Presentation THT 2025

Worsening Renal Function Is Common And Associated With Increased Mortality In Cardiogenic Shock: An Analysis From The Multi-Center Cardiogenic Shock Working Group (CSWG) Registry

Presenter: Rachna Kataria

February 12, 2025

Presentation THT 2025

When to Use Devices the Recude Renal Vein Pressure

Presenter: Liviu Klein

February 12, 2025

News Conference News THT 2025

Reprieve System Safely Aids Decongestion in Acute HF: FASTR Pilot RCT

Todd Neale

February 11, 2025

Presentation THT 2025

Association of SGLT2 Inhibitors With Clinical Outcomes in Patients With Severe Renal Impairment (Estimated Glomerular Filtration Rate < 30) and Heart Failure With Reduced Ejection Fraction (HFrEF)

Presenter: Jonathan Zawadzki

February 11, 2025

Presentation THT 2025

Renal Dysfunction as a Primary Mechanism of Symptoms in (Most) Patients With HFpEF

Presenter: Jeffrey Testani

February 11, 2025

Presentation THT 2024

Safety and Feasibility Assessment of the Doraya, a Renal Venous Afterload Modulator, for the Treatment of Volume Overload in Acute Heart Failure Patients with Insufficient Response to Diuretics

Presenter: Lucas Zier

March 06, 2024

Presentation THT 2024

Blood Volume Profiles and Correlations with Pressures in Heart Failure with Impaired Renal Function

Presenter: Veraprapas Kittipibul

March 05, 2024

News Conference News THT 2024

Debating the Role of T-TEER in the Sickest Patients

Michael O'Riordan

March 05, 2024

Presentation THT 2024

Physiological Effects of Renal Denervation in Patients With HFpEF

Presenter: Karl-Philipp Rommel

March 04, 2024

Presentation THT 2024

Renal Replacement Therapies for ADHF: Aquaphoresis, Hemofiltration and Beyond

Presenter: Sean P. Pinney

March 04, 2024

News Features THT 2023

The Promise of AI for Improving Health Equity in Heart Failure

Todd Neale

April 04, 2023

News Conference News THT 2023

Preliminary Results Suggest Benefit of Splanchnic Nerve Ablation in HFpEF

Todd Neale

March 22, 2023

Presentation THT 2023

The Nephronyx Perfuser: A Novel Device That Targets Increased Renal Venous Pressure in Patient With Cardiorenal Syndrome

Presenter: Oren Caspi

March 21, 2023

Presentation THT 2023

Pilot Evaluation of the Use of Prolonged Low-Intensity Ultrasound Delivery to the Kidney in Acutely Decompensated Heart Failure Patients With Renal Deficiency

Presenter: Benny Rousso

March 21, 2023

Presentation THT 2023

Prolonged Low-intensity Ultrasound Delivery to the Kidney, As a Technology For Potential Treatment Option For Acutely Decompensated Heart Failure Patients With Renal Deficiency

Presenter: Benny Rousso

March 21, 2023

Presentation THT 2023

Pullers: Devices That Reduce Renal Vein Pressure

Presenter: Navin Kapur

March 20, 2023

Presentation THT 2023

Pushers: Devices That Increase Renal Arterial Pressure

Presenter: Jennifer Cowger

March 20, 2023

News Conference News THT 2022

Cardiogenic Shock’s Origins, Progression Tightly Tied to Mortality

Caitlin E. Cox

February 07, 2022

News Conference News THT 2022

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Caitlin E. Cox

February 02, 2022

Advertisement

Safety and Feasibility of Renal Venous Afterload Modulation With the Doraya in Acute Decompensated Heart Failure and Persistent Congestion From Insufficient Response to Diuretic Therapy

Worsening Renal Function Is Common And Associated With Increased Mortality In Cardiogenic Shock: An Analysis From The Multi-Center Cardiogenic Shock Working Group (CSWG) Registry

When to Use Devices the Recude Renal Vein Pressure

Reprieve System Safely Aids Decongestion in Acute HF: FASTR Pilot RCT

Association of SGLT2 Inhibitors With Clinical Outcomes in Patients With Severe Renal Impairment (Estimated Glomerular Filtration Rate < 30) and Heart Failure With Reduced Ejection Fraction (HFrEF)

Renal Dysfunction as a Primary Mechanism of Symptoms in (Most) Patients With HFpEF

Safety and Feasibility Assessment of the Doraya, a Renal Venous Afterload Modulator, for the Treatment of Volume Overload in Acute Heart Failure Patients with Insufficient Response to Diuretics

Blood Volume Profiles and Correlations with Pressures in Heart Failure with Impaired Renal Function

Debating the Role of T-TEER in the Sickest Patients

Physiological Effects of Renal Denervation in Patients With HFpEF

Renal Replacement Therapies for ADHF: Aquaphoresis, Hemofiltration and Beyond

The Promise of AI for Improving Health Equity in Heart Failure

Preliminary Results Suggest Benefit of Splanchnic Nerve Ablation in HFpEF

The Nephronyx Perfuser: A Novel Device That Targets Increased Renal Venous Pressure in Patient With Cardiorenal Syndrome

Pilot Evaluation of the Use of Prolonged Low-Intensity Ultrasound Delivery to the Kidney in Acutely Decompensated Heart Failure Patients With Renal Deficiency

Prolonged Low-intensity Ultrasound Delivery to the Kidney, As a Technology For Potential Treatment Option For Acutely Decompensated Heart Failure Patients With Renal Deficiency

Pullers: Devices That Reduce Renal Vein Pressure

Pushers: Devices That Increase Renal Arterial Pressure

Cardiogenic Shock’s Origins, Progression Tightly Tied to Mortality

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content